Inventor
Bruce G. Szczepankiewicz
Inventor
Hopkinton, MA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes15%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
C07HSugars10%
C07BGeneral methods of organic chemistry4%
C07CAcyclic or carbocyclic compounds4%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for2%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation2%
A61QSpecific use of cosmetics or similar toiletry preparations2%
PatentTitleYear
10,618,927Compositions and methods for modulation of nicotinamide adenine dinucleotide202010,590,135Substituted bridged urea analogs as sirtuin modulators202010,548,913Nicotinamide mononucleotide derivatives and their uses202010,485,814Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof201910,316,054Preparation and use of crystalline beta-D-nicotinamide riboside20199,834,558Substituted bridged urea analogs as sirtuin modulators20179,765,075'Substituted bridged urea analogs as sirtuin modulators'20179,376,461'Non-enzymatic synthesis of O-acetyl-ADP-ribose and analogues thereof'20168,637,546'Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV)'20148,119,664'Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)'20127,888,374'Inhibitors of c-jun N-terminal kinases'20117,365,093'Endothelin antagonists'20087,262,207'Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)'20077,238,724'Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)'20077,208,517'Endothelin antagonists'20077,169,797'Protein-tyrosine phosphatase inhibitors and uses thereof'20076,972,340'Selective protein tyrosine phosphatatase inhibitors'20056,946,481'Endothelin antagonists'20056,693,123'Inhibitors of protein isoprenyl transferases'20046,462,194'Endothelin antagonists'20026,380,241'Treatment of diseases using endothelin antagonists'20026,162,927'Endothelin antagonists'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2012Patents assigned to ABBOTT LAB (11)· patent assignee history
2000–2008Based in Gages Lake, IL, US· patent location history
2004–2007Based in Lindenhurst, IL, US· patent location history
2007–2014Based in Wildwood, IL, US· patent location history
2012–2016Patents assigned to SZCZEPANKIEWICZ BRUCE G (3)· patent assignee history
2012–2014Patents assigned to DJURIC STEVAN W (2)· patent assignee history
2016–2020Patents assigned to GLAXOSMITHKLINE LLC (4)· patent assignee history
2017–2020Based in Hopkinton, MA, US· patent location history
2019Patents assigned to GLAXOSMITHKLINE IP NO 2 LTD (2)· patent assignee history
2020Based in Worcester, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBOTT LAB | 11 | 2000–2012 |
| GLAXOSMITHKLINE LLC | 4 | 2016–2020 |
| SZCZEPANKIEWICZ BRUCE Gself | 3 | 2012–2016 |
| DJURIC STEVAN W | 2 | 2012–2014 |
| GLAXOSMITHKLINE IP NO 2 LTD | 2 | 2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Hopkinton, Massachusetts, US | 6 | 2017–2020 |
| Gages Lake, Illinois, US | 6 | 2000–2008 |
| Wildwood, Illinois, US | 4 | 2007–2014 |
| Lindenhurst, Illinois, US | 3 | 2004–2007 |
| Worcester, Massachusetts, US | 1 | 2020 |